AI's perimenopause supplement default doesn't exist yet. Here are the 6 brands holding the slot.

What the data actually says

Three perimenopause queries × 5 platforms = 15 query outputs. We extracted every brand named, scored by mention frequency and first-position rate. Six brands surfaced across the entire persona block:

Two of the six are Thorne extensions. One is Pfizer's Estroven, a brand that has owned the over-the-counter “menopause supplement” mental shelf for a decade. The remaining three appear once each.

For comparison, here is what the other personas look like by total brand-mention volume across the same 5 platforms × 3 prompts each:

Pregnancy has 8.75x more brand mentions and 8.5x more unique brands competing. Endurance athlete has 7x. Biohacker has 6x. Perimenopause is the structural outlier.

Why this happens

When AI gets asked a persona-led health question, the four LLM engines we tested behave the same way: they refuse to recommend specific brands and substitute one of three things — ingredient education (“magnesium glycinate is the best form for sleep”), peer-reviewed study summaries, or expert authority quotes. On perimenopause specifically, 67% of (prompt × platform) combinations returned zero brands. The substitute content is ingredient explanations and named-expert quotes (Dr Mary Claire Haver, Dr Jolene Brighten) without products attached.

Among the four LLMs, none reliably named brands on perimenopause prompts. Only the search-engine baseline surfaced brand-mentioning articles, because consumer-review and best-of listicles rank for these queries.

The result is an AI mental shelf that is mostly empty. There is no Thorne-equivalent that all 5 engines agree is the perimenopause default.

What's actually claimable

Three things make this market structurally claimable in the next 6-12 months, in a way that pregnancy or longevity are not:

Low competition density. With 6 brands surfaced versus 51 in pregnancy, the entry cost per unit of citation share is roughly 1/8 of pregnancy's. The same content investment moves a perimenopause brand from invisible to top-3 in a way it would not move a prenatal brand from #15 to #3.

No incumbent first-position winner. The top mentions are tied at 2. Compare to pregnancy, where Perelel Mom Multi has a clear 7-mention lead and 6 first-position wins. Perimenopause has no entrenched defender. Whoever invests in citation-worthy content first sets the default.

Zero brand-vs-brand contestation in AI memory yet. AI default associations — the kind that make ChatGPT say “Thorne” when asked about prenatal — calcify over 12-18 months once a brand has consistent multi-source coverage. Perimenopause has not yet reached the calcification phase. After it does, entry cost rises 5-10x. Collagen and omega-3 are past that point. Perimenopause is not.

What it means for content strategy

The straightforward reading — “optimize harder for ‘best supplements for perimenopause’” — does not work, because that prompt returns zero brands two-thirds of the time. Three concrete moves do:

1. Publish ingredient-authority content on the brand-owned domain. When AI substitutes “Brand X” with “magnesium glycinate is the best form for sleep”, the question becomes which authority AI cites for that claim. Brand-owned blogs with depth on ingredient science (livemomentous and omre.co are the strongest examples in our supplement-niche data — both rank in the top 25 source domains for citation share) appear inline as authority sources alongside publishers. The brand name appears in the citation context as a source, not as a recommendation. That is a different kind of visibility, and it works on prompts where direct brand recommendation does not.
2. Reframe the optimization target as brand-first prompts. “Best supplements for perimenopause” has a 67% zero-brand rate. “Best magnesium brand for menopause” or “Thorne Meta-Balance vs HUM Fan Club” has a 3% zero-brand rate. Brand-first phrasing extracts named brands. Build content around the queries AI will actually answer with brand names, then earn the brand placement on those queries.
3. Target the cited expert and publisher network, not the brand directly. When ChatGPT cites Dr Mary Claire Haver on perimenopause without naming products, the goal becomes “appear in a Dr Haver context” — research collaboration, podcast feature, peer-reviewed study co-authorship, or sponsored editorial that puts the brand in proximity to the expert AI already trusts. The brand does not go through ChatGPT directly; it goes through the source ChatGPT cites.

There is also a structural move: invest in the third-party-testing certification that AI weighs heavily on commercial-intent prompts. Across our 47 prompts, brands carrying explicit Clean Label Project, NSF, USP, or Informed Sport certification surfaced roughly 30% more often than non-certified peers. Clean Label Project specifically lifts women-targeted brands on trust-cert prompts (Ritual, MaryRuth's, Pink Stork, HUM, SmartyPants are all in this group). Earning the certification first, then documenting it on the brand-owned domain in extractable AI-friendly content (named test, named lab, dated certificate) is a force multiplier.

The 12-month window

The perimenopause supplement category is one of the fastest-growing health verticals globally, driven by demographic shifts. Investor-funded entrants are arriving quickly. AI's brand defaults usually stabilize after a category accumulates 12-18 months of consistent multi-source brand-domain coverage. We watched that happen in the 2024-2025 window for collagen, NMN, and apigenin. The next category to consolidate will be perimenopause — but not yet.

The brands that publish citation-worthy ingredient-authority content over the next 6-12 months, earn third-party testing certification with on-domain documentation, and get featured in the expert and publisher contexts AI already trusts will become AI's perimenopause defaults. Brands that wait until the category consolidates will pay 5-10x more for the same visibility return.

What you can do now

• Audit which queries in the perimenopause/menopause cluster surface your brand, your competitors, or zero brands at all — across ChatGPT, Claude, and Perplexity.
• Map which expert and publisher contexts AI cites on those queries, and identify which of them are addressable through partnership or editorial placement.
• Identify the third-party testing certifications the women's health AEO winners share, and check whether your brand's certifications are documented in extractable form on your own domain.